Skip to main content
Related Topic: Health


  • Biologics are the fastest growing sector of the prescription drug market.
  • Biosimilars must meet the U.S. Food and Drug Administration’s (FDA) rigorous approval standards before it is considered interchangeable with its biologic reference product.
  • IQVIA estimates that savings from using biosimilars could save up to $183 billion over the next five years.

DO NOT DELETE - NCSL Page Search Data

Related Resources

State Public Health Legislation Database

This database covers topics related to public health including infectious disease prevention and treatment, public health reporting and workforce and vaccines. It includes all introduced legislation from 2021 to the present and is updated at least twice per month as legislation is identified by NCSL staff.
  • Contact NCSL

  • For more information on this topic, use this form to reach NCSL staff.